The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Open accessAbstract
BACKGROUND: The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS: We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS: After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS: In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prediabetes is linked with increased risks of major manifestations of vascular disease, but it remains unclear whether the elevated disease risks depend on development of clinical diabetes.84,85”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“A recent individual-level evidence from prospective studies suggests that fasting hyperglycaemia (figure 3), postload glucose, and A1c are all robust predictors of vascular mortality86,88,89 and, according to multivariable adjusted analyses, these associations are independent of vascular risk factors, such as obesity, blood pressure, triglyceride and lipoproteins.84,85,87”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“The study found that a 50-year-old with T2DM died, on average, 6 years earlier than an individual without T2DM, with about 40% of the difference in survival attributable to excess non-vascular deaths.95”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“Aside from CV death, results from the Emerging Risk Factors Collaboration, including 820 900 people, demonstrate that T2DM is independently associated with increased risk of death from several cancers (i.e.liver, pancreas, ovary, colorectum, lung, bladder, and breast), renal and liver disease, pneumonia and other infectious diseases, mental and nervous system disorders, non-hepatic digestive dis”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“These are consistent with downward secular trends in cardiovascular disease and improvements in mortality and are in line with previously reported estimates of the reduction in life expectancy due to diabetes [23].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Self-citationMortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,010
Vallejo‐Vaz, A. J., Akram, A., Seshasai, S. R. K., Cole, D., Watts, G. F., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., et al. (2016) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2016.10.001 · Cited by 113
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 114
Su, W., Chen, S., Huang, Y.-T., Huang, J., Wu, P.-Y., Hsu, W., & Lee, M. (2019) · Nutrients · doi:10.3390/nu11112838 · Cited by 113
Alonso-Morán, E., Orueta, J. F., Esteban, J. I. F., Axpe, J. M. A., González, M. L. M., Polanco, N. T., Loiola, P. E., Gaztambide, S., & Nuño-Solinis, R. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1059 · Cited by 110
Lin, D. S.-H., Lee, J.-K., Hung, C.-S., & Chen, W.-J. (2021) · Diabetologia · doi:10.1007/s00125-021-05529-w · Cited by 108
Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience
Zinman, B., Marso, S. P., Christiansen, E., Calanna, S., Rasmussen, S., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dc17-2677 · Cited by 109
Sabanayagam, C., Chee, M. L., Banu, R., Cheng, C., Lim, S. C., Tai, E. S., Coffman, T. M., & Wong, T. Y. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1540 · Cited by 108
Ezzatvar, Y., & García‐Hermoso, A. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110194 · Cited by 108
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
Holman, R. R., Bethel, M. A., George, J. T., Sourij, H., Doran, Z., Keenan, J. F., Khurmi, N. S., Mentz, R. J., Oulhaj, A., Buse, J. B., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.12.009 · Cited by 105
Alcoholic Beverage Consumption and Chronic Diseases
Zhou, Y., Zheng, J., Li, S., Zhou, T., Zhang, P., & Li, H. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13060522 · Cited by 109
Cardiovascular Consequences of New-Onset Hyperglycemia After Kidney Transplantation
Wauters, R. P., Cosio, F. G., Fernández, M., Kudva, Y. C., Shah, P. R., & Torres, V. E. (2012) · Transplantation · doi:10.1097/tp.0b013e3182584831 · Cited by 106
Bongaerts, B. W. C., Rathmann, W., Heier, M., Kowall, B., Herder, C., Stöckl, D., Meisinger, C., & Ziegler, D. (2012) · Diabetes Care · doi:10.2337/dc12-0744 · Cited by 112
Fundamental Concepts Regarding Testosterone Deficiency and Treatment
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.007 · Cited by 109
Rubio, J. A., Jiménez, S., & Lázaro‐Martínez, J. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9093009 · Cited by 117
Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis
Crudele, L., Piccinin, E., & Moschetta, A. (2021) · Nutrients · doi:10.3390/nu13062101 · Cited by 114
Ramos‐García, P., Roca-Rodríguez, M. D. M., Aguilar‐Diosdado, M., & González‐Moles, M. Á. (2020) · Oral Diseases · doi:10.1111/odi.13289 · Cited by 113
Clinical Characteristics of 28 Patients with Diabetes and COVID-19 in Wuhan, China
Wang, F., Yang, Y., Dong, K., Yan, Y., Zhang, S., Ren, H., Yu, X., & Shi, X. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0108 · Cited by 105
Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M
Albiero, M., Poncina, N., Ciciliot, S., Cappellari, R., Menegazzo, L., Ferraro, F., Bolego, C., Cignarella, A., Avogaro, A., & Fadini, G. P. (2015) · Diabetes · doi:10.2337/db14-1473 · Cited by 104
Diabetes Prevalence in Sweden at Present and Projections for Year 2050
Andersson, T., Ahlbom, A., & Carlsson, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143084 · Cited by 104
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients
Sciacca, L., Vigneri, R., Tumminia, A., Frasca, F., Squatrito, S., Frittitta, L., & Vigneri, P. G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.05.006 · Cited by 105
Lee, C. G., Heckman‐Stoddard, B. M., Dabelea, D., Gadde, K. M., Ehrmann, D. A., Ford, L., Prorok, P. C., Boyko, E. J., Pi-Sunyer, X., Wallia, A., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1046 · Cited by 101
The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes
Lind, M., Olsson, M., Rosengren, A. H., Svensson, A., Bounias, I., & Guðbjörnsdóttir, S. (2012) · Diabetologia · doi:10.1007/s00125-012-2681-3 · Cited by 102
Zheng, Y., Li, Y., Rimm, E. B., Hu, F. B., Albert, C. M., Rexrode, K. M., Manson, J. E., & Qi, L. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.131771 · Cited by 100
Kowall, B., Stang, A., Rathmann, W., & Kostev, K. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3823 · Cited by 100
Influence of Lifestyle Factors on Breast Cancer Risk
Dieterich, M., Stubert, J., Reimer, T., Erickson, N. T., & Berling, A. (2014) · Breast Care · doi:10.1159/000369571 · Cited by 107
An, Y., Zhang, P., Wang, J., Gong, Q., Gregg, E. W., Yang, W., Li, H., Zhang, B., Shuai, Y., Chen, Y., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2498 · Cited by 99
Arvandi, M., Strasser, B., Meisinger, C., Volaklis, K. A., Gothe, R. M., Siebert, U., Ladwig, K., Grill, E., Horsch, A., Laxy, M., et al. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0381-4 · Cited by 103
Ray, K. K., Nicholls, S. J., Li, N., Louie, M. J., Brennan, D., Lincoff, A. M., & Nissen, S. E. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00316-9 · Cited by 99
Diabetes in the Western Pacific Region—Past, Present and Future
Chan, J. C. N., Cho, N. H., Tajima, N., & Shaw, J. E. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.012 · Cited by 99
Sattar, N. A., Ginsberg, H. N., Ray, K. K., Chapman, M. J., Arca, M., Averna, M. R., Betteridge, D. J., Bhatnagar, D., Bilianou, E., Carmena, R., et al. (2014) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2014.04.001 · Cited by 99
Posteraro, B., Torelli, R., Vella, A., Leone, P. M., Angelis, G. D., Carolis, E. D., Ventura, G., Sanguinetti, M., & Fantoni, M. (2020) · Journal of Fungi · doi:10.3390/jof6030163 · Cited by 100
Escolar, E., Lamas, G. A., Mark, D. B., Boineau, R., Goertz, C., Rosenberg, Y., Nahin, R. L., Ouyang, P., Rozema, T. C., Magaziner, A., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000663 · Cited by 100
Brinkhues, S., Dukers-Muijrers, N. H. T. M., Hoebe, C. J. P. A., van der Kallen, C. J. H., Dagnelie, P. C., Koster, A., Henry, R. M. A., Sep, S. J. S., Schaper, N. C., Stehouwer, C. D. A., et al. (2017) · BMC Public Health · doi:10.1186/s12889-017-4948-6 · Cited by 97
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients
Rigato, M., Bittante, C., Albiero, M., Avogaro, A., & Fadini, G. P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1687 · Cited by 98
The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
Pollak, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0998 · Cited by 97
Moradi‐Lakeh, M., Forouzanfar, M. H., Bcheraoui, C. E., Daoud, F., Afshin, A., Hanson, S. W., Vos, T., Naghavi, M., Murray, C. J. L., Mokdad, A. H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1075 · Cited by 103
Battineni, G., Sagaro, G. G., Chintalapudi, N., Amenta, F., & Tayebati, S. K. (2019) · Machines · doi:10.3390/machines7040074 · Cited by 106
Mortality Rates in Trials of Subjects With Type 2 Diabetes
Barkoudah, E., Skali, H., Uno, H., Solomon, S. D., & Pfeffer, M. A. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000059 · Cited by 98
Aikaeli, F., Njim, T. N., Gissing, S., Moyo, F., Alam, U., Mfinanga, S., Okebe, J., Ramaiya, K. L., Webb, E. L., Jaffar, S. S., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000599 · Cited by 104
Hepatic glucose sensing and integrative pathways in the liver
Oosterveer, M. H., & Schoonjans, K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1505-z · Cited by 102
Moody, A., Cowley, G., Fat, L. N., & Mindell, J. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010155 · Cited by 99
van der Heijden, A. A. W. A., Rauh, S. P., Dekker, J. M., Beulens, J. W. J., Elders, P. J. M., Hart, L. M. ‘., Rutters, F., van Leeuwen, N., & Nijpels, G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015599 · Cited by 92
Ueki, K., Sasako, T., Okazaki, Y., Miyake, K., Nangaku, M., Ohashi, Y., Noda, M., & Kadowaki, T. (2021) · Kidney International · doi:10.1016/j.kint.2020.08.012 · Cited by 94
Crooks, C. J., West, J., & Card, T. R. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007974 · Cited by 99
Fadini, G. P., Ciciliot, S., & Albiero, M. (2016) · Stem Cells · doi:10.1002/stem.2445 · Cited by 95
Steinarsson, A. O., Rawshani, A., Guðbjörnsdóttir, S., Franzén, S., Svensson, A., & Sattar, N. A. (2018) · Diabetologia · doi:10.1007/s00125-017-4532-8 · Cited by 94
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
Newman, J. D., Vani, A. K., Alemán, J. O., WEINTRAUB, H. S., Berger, J. S., & Schwartzbard, A. Z. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.071 · Cited by 95
Diabetic nephropathy in Africa: A systematic review
Noubiap, J. J. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i5.759 · Cited by 95
McDonald, H. I., Nitsch, D., Millett, E. R. C., Sinclair, A. J., & Thomas, S. L. (2013) · Diabetic Medicine · doi:10.1111/dme.12384 · Cited by 94
Lynge, T. H., Svane, J., Pedersen‐Bjergaard, U., Gislason, G., Torp-Pedersen, C. T., Banner, J., Risgaard, B., Winkel, B. G., & Tfelt‐Hansen, J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz891 · Cited by 93
Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty
Ponce, B. A., Menendez, M. E., Oladeji, L. O., & Soldado, F. (2014) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2014.01.046 · Cited by 94
Zhu, Z., Wang, X., Shen, Z., Lu, Y., Zhong, S., & Chen, X. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-310 · Cited by 93
Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
Lee, C., Jung, M., Jung, I., Heo, S. J., Jeong, Y. H., An, J. Y., Kim, H., Cheong, J., Hyung, W. J., Noh, S. H., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001086 · Cited by 92
Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments
Zaccardi, F., Htike, Z. Z., Webb, D. R., Khunti, K., & Davies, M. J. (2015) · Annals of Internal Medicine · doi:10.7326/m15-1432 · Cited by 95
Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study
Kowall, B., Rathmann, W., Stang, A., Bongaerts, B. W. C., Kuß, O., Herder, C., Roden, M., Quante, A. S., Holle, R., Huth, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171152 · Cited by 92
Dave, C. V., Kim, S. C., Goldfine, A. B., Glynn, R. J., Tong, A., & Patorno, E. (2020) · Circulation · doi:10.1161/circulationaha.120.047965 · Cited by 97
Association between systemic immune-inflammation index and cardiovascular-kidney-metabolic syndrome
Gao, C., Gao, S., Zhao, R., Shen, P., Zhu, X., Yang, Y., Duan, C., Wang, Y., Ni, H., Zhou, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69819-0 · Cited by 92
Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes
Ke, C., Lau, E. S. H., Shah, B. R., Stukel, T. A., Ronald, C. W., So, W., Kong, A. P. S., Chow, E., Clarke, P., Goggins, W. B., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1900 · Cited by 92
Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies
Bosetti, C., Rosato, V., Polesel, J., Levi, F., Talamini, R., Montella, M., Negri, E., Tavani, A., Zucchetto, A., Franceschi, S., et al. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.676141 · Cited by 91
Iwaya, C., Nomiyama, T., Komatsu, S., Kawanami, T., Tsutsumi, Y., Hamaguchi, Y., Horikawa, T., Yoshinaga, Y., Yamashita, S.-I., Tanaka, T., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00461 · Cited by 96
Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
Segar, M. W., Khan, M. S., Patel, K. V., Butler, J., Tang, W. H. W., Vaduganathan, M., Lam, C. S. P., Verma, S., McGuire, D. K., & Pandey, A. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.08.020 · Cited by 90
Gong, Y., Wei, B.-J., Li, Y., & Pan, W. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.01.003 · Cited by 93
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus
Kirkman, M. S., Mahmud, H., & Korytkowski, M. T. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.002 · Cited by 88
Precision prognostics for the development of complications in diabetes
Schiborn, C., & Schulze, M. B. (2022) · Diabetologia · doi:10.1007/s00125-022-05731-4 · Cited by 103
Latest insights into the risk of cancer in diabetes
Noto, H., Goto, A., Tsujimoto, T., Osame, K., & Noda, M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12068 · Cited by 90
Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes
Stępień, E. Ł., Durak-Kozica, M., Kamińska, A., Targosz‐Korecka, M., Libera, M., Tylko, G., Opalinska, A., Kapusta, M., Solnica, B., Georgescu, A., et al. (2018) · Theranostics · doi:10.7150/thno.23334 · Cited by 88
Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
Yamagishi, S., & Matsui, T. (2018) · Annals of Vascular Diseases · doi:10.3400/avd.ra.18-00070 · Cited by 97
SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects
Garofalo, C., Borrelli, S., Liberti, M., Andreucci, M., Conte, G., Minutolo, R., Provenzano, M., & Nicola, L. D. (2019) · Medicina · doi:10.3390/medicina55060268 · Cited by 95
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation
Komatsu, S., Nomiyama, T., Numata, T., Kawanami, T., Hamaguchi, Y., Iwaya, C., Horikawa, T., Fujimura-Tanaka, Y., Hamanoue, N., Motonaga, R., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0428 · Cited by 88
Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes
Menzaghi, C., Bacci, S., Salvemini, L., Mendonça, C., Palladino, G., Fontana, A., Bonis, C. D., Marucci, A., Goheen, E., Prudente, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064729 · Cited by 87
Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study
Sturlaugsdottir, R., Aspelund, T., Björnsdóttir, G., Sigurdsson, S. O., Þórsson, B., Eiríksdóttir, G., & Gudnason, V. G. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012457 · Cited by 86
Insights into the relationships between diabetes, prediabetes, and cancer
Scappaticcio, L., Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2016) · Endocrine · doi:10.1007/s12020-016-1216-y · Cited by 89
Lin, X., Brennan‐Speranza, T. C., Levinger, I., & Yeap, B. B. (2018) · Nutrients · doi:10.3390/nu10070847 · Cited by 88
Fadini, G. P., Rigato, M., Cappellari, R., Bonora, B. M., & Avogaro, A. (2016) · Diabetes Care · doi:10.2337/dc16-1755 · Cited by 86
Han, S. J., Ha, K. H., Lee, N., & Kim, D. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14261 · Cited by 90
Survival Among Patients With Pancreatic Cancer and Long-Standing or Recent-Onset Diabetes Mellitus
Yuan, C., Rubinson, D. A., Qian, Z. R., Wu, C. H., Kraft, P. L., Bao, Y., Ogino, S., Ng, K., Clancy, T. E., Swanson, R. S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.5688 · Cited by 87
Cao, Y. L., Zou, S., Xu, H., Li, M., Tong, Z., Xu, M. H., & Xu, X. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600032 · Cited by 88
Alramadan, M. J., Magliano, D. J., Almigbal, T. H., Batais, M. A., Afroz, A., Alramadhan, H. J., Mahfoud, W. F., Alragas, A. M., & Billah, B. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0292-9 · Cited by 91
Bérubé, S., Lemieux, J., Moore, L., Maunsell, E., & Brisson, J. (2014) · Breast Cancer Research · doi:10.1186/bcr3646 · Cited by 85
Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease
Platt, T. L., Beckett, T. L., Köhler, K., Niedowicz, D. M., & Murphy, M. P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.011 · Cited by 87
Pham-Hua, D., Padgett, L. E., Xue, B., Anderson, B. M., Zeiger, M., Barra, J. M., Bethea, M. M., Hunter, C. S., Kozlovskaya, V., Kharlampieva, E., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.002 · Cited by 83
Jacobs, E. M. G., Hoyer, A., Brinks, R., Kuß, O., & Rathmann, W. (2017) · Diabetes Care · doi:10.2337/dc17-0954 · Cited by 84
Hamer, M., O’Donovan, G., & Stamatakis, E. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2019.03.002 · Cited by 87
Rahman, M. S., & Woollard, K. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_7 · Cited by 87
Khan, S., Ullah, H., Rahim, F., Nawaz, M., Hussain, R., & Rasheed, L. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133812 · Cited by 84
Molecular insights of exercise therapy in disease prevention and treatment
Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 95
The association between diabetes and breast cancer stage at diagnosis: a population-based study
Lipscombe, L. L., Fischer, H. D., Austin, P. C., Fu, L., Jaakkimainen, R. L., Ginsburg, O., Rochon, P. A., Narod, S. A., & Paszat, L. F. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3323-5 · Cited by 84
Fraz, M. M., Welikala, R. A., Rudnicka, A. R., Owen, C. G., Strachan, D. P., & Barman, S. A. (2015) · Expert Systems with Applications · doi:10.1016/j.eswa.2015.05.022 · Cited by 84
Acute Hyperglycemia Associated with Anti-Cancer Medication
Hwangbo, Y., & Lee, E. K. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.1.23 · Cited by 83
Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients
Lo, S., Chang, S., Muo, C., Chen, S., Liao, F., Dee, S., Chen, P., & Sung, F. (2012) · International Journal of Cancer · doi:10.1002/ijc.27597 · Cited by 83
Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes
Scheen, A. J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.05.2659 · Cited by 81
Joung, K. H., Jeong, J., & Ku, B. J. (2015) · BioMed Research International · doi:10.1155/2015/920618 · Cited by 86
Journal of Experimental and Clinical Medicine
(2021) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm · Cited by 80
Gallwitz, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1004044 · Cited by 81
Saito, I. (2012) · Circulation Journal · doi:10.1253/circj.cj-11-1519 · Cited by 81
Wu, I., Lin, C., & Hsiung, C. A. (2015) · Biomedicine · doi:10.7603/s40681-015-0001-1 · Cited by 83
Sakamoto, M., Nishimura, R., Irako, T., Tsujino, D., Ando, K., & Utsunomiya, K. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-92 · Cited by 81
Fasting blood glucose as a predictor of mortality: Lost in translation
Palliyaguru, D. L., Shiroma, E. J., Nam, J. K., Duregon, E., Teixeira, C. V. L., Price, N. L., Bernier, M., Camandola, S., Vaughan, K. L., Colman, R. J., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.013 · Cited by 81
Survey of primary care providers’ knowledge of screening for, diagnosing and managing prediabetes
Tseng, E., Greer, R. C., O’Rourke, P., Yeh, H., McGuire, M., Clark, J. M., & Maruthur, N. M. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4103-1 · Cited by 87
Cao, Y. L., Sun, Y., Zou, S., Li, M., & Xu, X. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03782 · Cited by 82
Metadata
- Authors
- The Emerging Risk Factors Collaboration
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- The Emerging Risk Factors Collaboration
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-03-03
- Volume
- 364
- Issue
- 9
- Pages
- 829-841
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4109980
- OpenAlex
- W2126919962
- Semantic Scholar
- a89247dcde559e5839cef19b130059e2ad9abc75
- Cited by
- 2,726
- References
- 40
- Citations by year
- 2026: 102 · 2025: 138 · 2024: 186 · 2023: 151 · 2022: 200 · 2021: 225 · 2020: 218 · 2019: 182 · 2018: 190 · 2017: 203 · 2016: 190 · 2015: 196 · 2014: 193 · 2013: 145 · 2012: 147
- FWCI
- 141.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/013/25942, RG/08/014, PG/09/002/26056, RG/07/008/23674, RG/08/014/24067)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc085083-027, n01hc085080-026, n01hc085086-022, UL1TR000062, n01hc55222-0-0-0)
- Economic and Social Research Council (ES/G007438/1)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (N01 HC085086, N01 HC085079, N01 HC085083, N01 HC085080, HHSN 268200800007C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081)
- National Center for Research Resources (UL1RR025014)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, fasting blood glucose, hyperglycemia, cause-specific mortality, cancer mortality, vascular death, premature mortality, liver cancer, pancreatic cancer, ovarian cancer, colorectal cancer, lung cancer, breast cancer, renal disease mortality, infectious disease mortality, intentional self-harm, chronic obstructive pulmonary disease, mortality risk factors
- MeSH terms
- Blood Glucose, Cause of Death, Diabetes Mellitus, Female, Humans, Hyperglycemia, Life Expectancy, Male, Middle Aged, Risk, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
